Latest period
780M
YoY change
-0.1%
5Y CAGR
+3.5%
Peak year (FY1999)
888M
Latest annual
781M
Shares Outstanding history chart for AstraZeneca (AZN) from 2016 to 2025
Latest: 781M
Shares Outstanding growth chart for AstraZeneca (AZN) from 2016 to 2025
Latest: -0.1%
Shares Outstanding history table for AstraZeneca (AZN) from 1990 to 2025
| FY2025 | 781M | -0.1% | -500K | ||
| FY2024 | 782M | +0.1% | +500K | ||
| FY2023 | 781M | +0.1% | +1M | ||
| FY2022 | 780M | +9.3% | +66.5M | ||
| FY2021 | 714M | +8.7% | +57M | ||
| FY2020 | 657M | +0.9% | +6M | ||
| FY2019 | 651M | +2.7% | +17M | ||
| FY2018 | 634M | 0.0% | 0 | ||
| FY2017 | 634M | +0.1% | +500K | ||
| FY2016 | 633M | +0.1% | +500K | ||
| FY2015 | 633M | +0.1% | +500K | ||
| FY2014 | 632M | +0.8% | +5M | ||
| FY2013 | 627M | -0.8% | -5M | ||
| FY2012 | 632M | -7.5% | -51.5M | ||
| FY2011 | 684M | -5.5% | -39.5M | ||
| FY2010 | 723M | -0.3% | -2M | ||
| FY2009 | 725M | -0.2% | -1.5M | ||
| FY2008 | 727M | -3.0% | -22.5M | ||
| FY2007 | 749M | -4.6% | -36M | ||
| FY2006 | 785M | -3.0% | -24M | ||
| FY2005 | 809M | -3.3% | -27.5M | ||
| FY2004 | 837M | -2.1% | -18M | ||
| FY2003 | 855M | -1.5% | -13M | ||
| FY2002 | 868M | -1.3% | -11.5M | ||
| FY2001 | 879M | -0.6% | -5M | ||
| FY2000 | 884M | -0.5% | -4M | ||
| FY1999 | 888M | +90.2% | +421M | ||
| FY1998 | 467M | -1.8% | -8.7M | ||
| FY1997 | 476M | +0.4% | +2M | ||
| FY1996 | 474M | +0.1% | +500K | ||
| FY1995 | 473M | 0.0% | 0 | ||
| FY1994 | 473M | +11.3% | +48M | ||
| FY1993 | 425M | +18.6% | +66.7M | ||
| FY1992 | 358M | 0.0% | 0 | ||
| FY1991 | 358M | 0.0% | 0 | ||
| FY1990 | 358M | — | — |
- FY2025781M-0.1%
- FY2024782M+0.1%
- FY2023781M+0.1%
- FY2022780M+9.3%
- FY2021714M+8.7%
- FY2020657M+0.9%
- FY2019651M+2.7%
- FY2018634M0.0%
- FY2017634M+0.1%
- FY2016633M+0.1%
- FY2015633M+0.1%
- FY2014632M+0.8%
- FY2013627M-0.8%
- FY2012632M-7.5%
- FY2011684M-5.5%
- FY2010723M-0.3%
- FY2009725M-0.2%
- FY2008727M-3.0%
- FY2007749M-4.6%
- FY2006785M-3.0%
- FY2005809M-3.3%
- FY2004837M-2.1%
- FY2003855M-1.5%
- FY2002868M-1.3%
- FY2001879M-0.6%
- FY2000884M-0.5%
- FY1999888M+90.2%
- FY1998467M-1.8%
- FY1997476M+0.4%
- FY1996474M+0.1%
- FY1995473M0.0%
- FY1994473M+11.3%
- FY1993425M+18.6%
- FY1992358M0.0%
- FY1991358M0.0%
- FY1990358M—
Shares Outstanding values are taken from AstraZeneca's reported income statements (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported diluted shares outstanding is 780M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of AstraZeneca (AZN) diluted shares outstanding is 781M – edged down 0.1% year-over-year.
Over 2020–2025 (5 years), AstraZeneca diluted shares outstanding expanded at a +3.5% compound annual rate, with mixed annual results across the window.
AstraZeneca diluted shares outstanding declined from 888M in 1999 to 781M in 2025, a 12.0% drawdown.
1999 marks the peak diluted shares outstanding at 888M, with the historical low of 358M recorded in 1990.
AstraZeneca Shares Outstanding by Year
AstraZeneca Shares Outstanding 2025: 781M
2025's diluted shares outstanding for AstraZeneca came in at 781M, edged down 0.1% below 2024.
AstraZeneca Shares Outstanding 2024: 782M
AstraZeneca posted diluted shares outstanding of 782M in 2024, edged up 0.1% from 2023.
AstraZeneca Shares Outstanding 2023: 781M
In 2023, AstraZeneca reported diluted shares outstanding of 781M, edged up 0.1% from 2022.
AstraZeneca Shares Outstanding 2022: 780M
AstraZeneca diluted shares outstanding in 2022 was 780M, grew 9.3% from 2021.
AstraZeneca Shares Outstanding 2021: 714M
AstraZeneca diluted shares outstanding in 2021 was 714M.
See more financial history for AstraZeneca (AZN).
Sector peers by Shares Outstanding
Healthcare peers of AstraZeneca (AZN), ranked by their latest diluted shares outstanding
Frequently asked questions
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.18% TTM
- Dividend Profile1.85% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.